Skip to results
Modify your search
NARROW
1-9 of 9
Authors: Christian Chidiac
Sort by
Journal Article
Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients Free
Cécile Pouderoux and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 7, July 2019, Pages 2060–2064, https://doi.org/10.1093/jac/dkz104
Published: 10 April 2019
Journal Article
Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection Free
Romain Bricca and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 4, April 2019, Pages 1012–1020, https://doi.org/10.1093/jac/dky541
Published: 09 January 2019
Journal Article
Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting Free
Lélia Abad and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 3, March 2019, Pages 625–632, https://doi.org/10.1093/jac/dky473
Published: 04 December 2018
Journal Article
Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages Free
Tristan Ferry and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 10, October 2018, Pages 2901–2903, https://doi.org/10.1093/jac/dky263
Published: 27 July 2018
Journal Article
EDITOR'S CHOICE
Population pharmacokinetics and probability of target attainment of ertapenem administered by subcutaneous or intravenous route in patients with bone and joint infection Free
Sylvain Goutelle and others
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 4, April 2018, Pages 987–994, https://doi.org/10.1093/jac/dkx477
Published: 13 December 2017
Journal Article
Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA Free
Céline Dupieux and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 12, December 2017, Pages 3353–3356, https://doi.org/10.1093/jac/dkx314
Published: 06 September 2017
Journal Article
Pristinamycin in the treatment of MSSA bone and joint infection—authors' response Free
F. Valour and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 11, November 2016, Page 3318, https://doi.org/10.1093/jac/dkw341
Published: 01 September 2016
Journal Article
Pristinamycin in the treatment of MSSA bone and joint infection Free
Florent Valour and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1063–1070, https://doi.org/10.1093/jac/dkv457
Published: 21 January 2016
Journal Article
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections
Get access
Gilles Beaucaire and others
Journal of Antimicrobial Chemotherapy, Volume 27, Issue suppl_C, 1991, Pages 91–103, https://doi.org/10.1093/jac/27.suppl_C.91
Published: 01 January 1991
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals